glp 1 brain GLP-1 for Weight Loss and Diabetes Study identifies new concepts for
Description
Impact on glycated haemoglobin and body weight changes after stopping tirzepatide for 4 weeks in the SURPASS-1 monotherapy trial
Metabolic brain disease, 37(2), 451462
doi: 10.1056/NEJMoa1504720 6 WannerCInzucchiSELachinJMFitchettDvon EynattenMMattheusMet al
Given how hard it is to get these medications for some patients, this can be an attractive alternative, but the FDA has expressed concern at the frequency of -glutide salts turning up in compounded formulations, which are not present in any of the FDA-approved drugs and thus have an unknown safety and efficacy profile
Andrea Ive never been so happy
